FDA Adverse Event Injury Summary report: N

XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 6210937 · Received December 28, 2016

Report

Report Number
2024168-2016-09297
Event Type
Injury
Date Received
December 28, 2016
Date of Event
August 1, 2015
Report Date
December 28, 2016
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
UDI-DI
08717648123641
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INTERNAL FILE NUMBER - (B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. DATES ESTIMATED. THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED; HOWEVER, THE REPORTED PATIENT EFFECT OF ANGINA IS LISTED IN THE XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE (IFU) AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING OF THE DEVICE.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2013, A 3.0X28MM XIENCE PRIME STENT WAS SUCCESSFULLY IMPLANTED IN THE MID LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY LESION AND A 3.5X28MM XIENCE PRIME STENT WAS SUCCESSFULLY IMPLANTED IN THE PROXIMAL LAD LESION. IN (B)(6) 2015, THE PATIENT WAS HOSPITALIZED FOR UNSTABLE CHEST PAIN. MEDICATION WAS PROVIDED AND THE EVENT RESOLVED WITHOUT SEQUELA. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
860470 XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 3050741 08717648123641

Patients

Seq Age Sex Outcome Treatment
1 65 YR Hospitalization| R XIENCE PRIME 3.5 X 28ASPIRIN, CLOPIDOGREL